Skip to main content
SpringerLink
Log in

Carcinoma in situ of the bladder

  • Published:
World Journal of Urology Aims and scope Submit manuscript

Summary

Carcinoma-in-situ of the bladder is a complex intraurothelial neoplasm. Although histologically confined to the superficial urothelium, the natural history of the lesion is unpredictable. In its most aggressive form, it is a diffuse field change process characterized by unremitting irritative voiding symptoms and is a harbinger of early muscle invasion. On the other hand, histologically identical, but focal CIS may be completely asymptomatic and remain dormant for decades without evidence of invasion or progression. The following review will address the pathologic, diagnostic, prognostic and therapeutic dilemmas facing the urologist in dealing with CIS.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Melicow MM (1952) Histological study of vesical urothelium intervening between gross neoplasms in total cystectomy. J Urol 68:261

    Google Scholar 

  2. Weinstein RS, Miller AW, Paul BU (1980) Carcinoma-in-situ: comments on the pathobiology of a paradox. Urol Clin North Am 7:523

    Google Scholar 

  3. Utz DC, Zincke H (1974) The masquerade of bladder cancer in situ as interstitial cystitis. J Urol 111:160

    Google Scholar 

  4. Collste LG, Devonec M, et al (1980) Bladder cancer diagnosis by flow cytometry. Correlation between cell samples from biopsy and bladder irrigation fluid. Cancer 45:2389

    Google Scholar 

  5. Klein FA, Whitmore WF Jr, et al (1982) Flow cytometry followup of patients with low stage bladder tumors. J Urol 128:88

    Google Scholar 

  6. Sharma TC, Melamed MR, Whitmore WF (1970) Carcinoma in situ of the ureter in patients with bladder cancer treated by cystectomy. Cancer 26:583

    Google Scholar 

  7. Seemayer TA, Knaack J, et al (1975) Further observation on carcinoma in situ of the urinary bladder: silent but extensive intra-prostatic involvement. Cancer 36:514

    Google Scholar 

  8. Utz DC, Farrow GM, et al (1980) Carcinoma-in-situ of the bladder. Cancer 45:1842

    Google Scholar 

  9. Melamed MR, Voutsa NG, Grabstald H (1961) Natural history and clinical behaviour of in situ carcinoma of the human bladder. Cancer 17:1533

    Google Scholar 

  10. Utz DC, Hanash KA, Farrow GM (1970) The plight of the patient with carcinoma-in-situ of the bladder. J Urol 103:160

    Google Scholar 

  11. Koss LG, Melamed MR, et al (1967) Carcinogenesis in the human urinary bladder. Observations after exposure to para-aminodipheryl. N Engl J Med 272:767

    Google Scholar 

  12. Koss LG, Melamed MR, Kelly RE (1969) Further cytologic and histologic studies of bladder lesions in workers exposed to para-aminophenyl: progress report. JNCI 43:233

    Google Scholar 

  13. Farrow CM, et al (1977) Clinical observations on 69 cases of in situ carcinoma of the urinary bladder. Cancer Res 37:2794

    Google Scholar 

  14. Devonec M, et al (1982) Flow cytometry of low stage bladder tumors: correlation with cytologic and cystoscopic diagnosis. Cancer 49:109

    Google Scholar 

  15. Limas C, Lange P (1980) A, B, H antigen dectability in normal and neoplastic urothelium. Cancer 49:2476

    Google Scholar 

  16. Javadpour N, Lippert M (1981) Cell surface antigen as tumor marker in bladder cancer. In: Conolly JG (ed) Progress in cancer research and therapy-carcinoma of the bladder, vol. 18. Raven Press, New York, p 112

    Google Scholar 

  17. Alroy J, Weinstein RS, Pauli BV (1976) Relation of desmosomes to tumor invasiveness in human urinary bladder transitional cell carcinomas. 73rd Annual Meeting of the American Association of Pathology and Bacteriology, p 31a

  18. Murphy WM, Soloway MS, et al (1981) Pathological changes associated with topical chemotherapy for superficial bladder cancer. J Urol 126:461

    Google Scholar 

  19. Jacobi GH, Kurth KH (1980) Studies on the intravesical action of topically administered G3H-doxorubicin hydrochloride in men: plasma uptake and tumor penetration. J Urol 124:34

    Google Scholar 

  20. Jakse G, Hofstädter F (1980) Intravesical doxorubicin hydrochloride in the management of carcinoma in situ of the bladder. A preliminary report. Eur Urol 6:103

    Google Scholar 

  21. Edsmyr F, Berlin T, et al (1980) Intravesical therapy with adriamycin in patients with superficial bladder tumors. Eur Urol 6:132

    Google Scholar 

  22. Herr HW, et al (1981) Effects of intravesical bacillus Calmette-Guerin (BCG) on carcinoma-in-situ of the bladder. 76th Annual Meeting of the American Urologic Association, Boston, Ma, May 1981 (abstr)

  23. Morales A, Eidinger D, Bruce AW (1976) Intracavitary bacillus Calmette-Guerin in the treatment of superficial bladder tumors. J Urol 116:180

    Google Scholar 

  24. Brosman SA (1982) Experience with bacillus Calmette-Guerin in patients with superficial bladder carcinoma. J Urol 128:27

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. University Hospital, Department of Urology, Boston University, 75 East Newton Street, 02118, Boston, Massachusetts, USA

    Richard K. Babayan & Robert J. Krane

Authors
  1. Richard K. Babayan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Robert J. Krane
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Babayan, R.K., Krane, R.J. Carcinoma in situ of the bladder. World J Urol 1, 70–73 (1983). https://doi.org/10.1007/BF00326745

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00326745

Keywords

Search

Navigation